Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Gandaglia

Showing results (1-10 of 650) with videos related to

Pageof 65
Sort By:
European Urology Oncology|February 9, 2022
Metastases-directed Therapies in the Prostate-specific Membrane Antigen Era: Not All That Glitters Is CurableGiorgio Gandaglia, Francesco Montorsi
Current Opinion in Urology|April 3, 2024
Editorial: Oligometastatic genitourinary cancerPawel Rajwa, Giorgio Gandaglia
Nature Reviews. Urology|December 19, 2013
Bladder cancer: Conditional survival after radical cystectomyGiorgio Gandaglia, Maxine Sun
European Urology Oncology|June 16, 2019
Re: Tom A. Hueting, Erik B. Cornel, Diederik M. Somford, et al. External Validation of Models Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients. Eur Urol Oncol 2018;1:411-7Giorgio Gandaglia, Francesco Montorsi
European Urology|September 11, 2014
Re: Georgios Gakis, Stephen A. Boorjian, Alberto Briganti, et al. The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature. Eur urol 2014;66:191-9Francesco Montorsi, Giorgio Gandaglia
European Urology|September 14, 2015
Do We Need a Novel Nephrometry Scoring System in Partial Nephrectomy?Alexandre Mottrie, Giorgio Gandaglia
European Urology|October 21, 2018
Re: Georg Jancke, Firas Aljabery, Sigurdur Gudjonsson, et al. Port-site Metastases After Robot-assisted Radical Cystectomy: Is There a Publication Bias? Eur Urol 2018;73:641-2Francesco Montorsi, Giorgio Gandaglia
European Urology Oncology|May 4, 2020
Key Prerequisites for the Correct Management of Intermediate-risk Prostate CancerFrancesco Montorsi, Giorgio Gandaglia
European Urology|September 17, 2014
Re: Paolo Gontero, Richard Sylvester, Francesca Pisano, et al. Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients. Eur Urol 2015;67:74-82Francesco Montorsi, Giorgio Gandaglia
European Urology|September 10, 2014
Sentinel node biopsy for prostate cancer: a useless surgical exercise?Francesco Montorsi, Giorgio Gandaglia
Pageof 65

Showing results (1-10 of 650) with videos related to

Sort By:
Pageof 65
European Urology Oncology|February 9, 2022
Metastases-directed Therapies in the Prostate-specific Membrane Antigen Era: Not All That Glitters Is CurableGiorgio Gandaglia, Francesco Montorsi
Current Opinion in Urology|April 3, 2024
Editorial: Oligometastatic genitourinary cancerPawel Rajwa, Giorgio Gandaglia
Nature Reviews. Urology|December 19, 2013
Bladder cancer: Conditional survival after radical cystectomyGiorgio Gandaglia, Maxine Sun
European Urology Oncology|June 16, 2019
Re: Tom A. Hueting, Erik B. Cornel, Diederik M. Somford, et al. External Validation of Models Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients. Eur Urol Oncol 2018;1:411-7Giorgio Gandaglia, Francesco Montorsi
European Urology|September 11, 2014
Re: Georgios Gakis, Stephen A. Boorjian, Alberto Briganti, et al. The role of radical prostatectomy and lymph node dissection in lymph node-positive prostate cancer: a systematic review of the literature. Eur urol 2014;66:191-9Francesco Montorsi, Giorgio Gandaglia
European Urology|September 14, 2015
Do We Need a Novel Nephrometry Scoring System in Partial Nephrectomy?Alexandre Mottrie, Giorgio Gandaglia
European Urology|October 21, 2018
Re: Georg Jancke, Firas Aljabery, Sigurdur Gudjonsson, et al. Port-site Metastases After Robot-assisted Radical Cystectomy: Is There a Publication Bias? Eur Urol 2018;73:641-2Francesco Montorsi, Giorgio Gandaglia
European Urology Oncology|May 4, 2020
Key Prerequisites for the Correct Management of Intermediate-risk Prostate CancerFrancesco Montorsi, Giorgio Gandaglia
European Urology|September 17, 2014
Re: Paolo Gontero, Richard Sylvester, Francesca Pisano, et al. Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients. Eur Urol 2015;67:74-82Francesco Montorsi, Giorgio Gandaglia
European Urology|September 10, 2014
Sentinel node biopsy for prostate cancer: a useless surgical exercise?Francesco Montorsi, Giorgio Gandaglia
Pageof 65